

| Salt Composition: | Progesterone (Natural Micronized) (200mg) |
| Manufacturer: | Alkem Laboratories Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Ultigest -SR 200 Tablet is a natural female sex hormone, progesterone, used to treat menstrual and pregnancy-related issues caused by hormonal imbalance. Ultigest -SR 200 Tablet is a natural progesterone available as a micronized formulation which helps in better absorption of this medicine. It is used as a part of hormone replacement therapy generally in combination with an estrogen. It may also be used in the treatment of problems related to menstrual periods such as amenorrhea (absence of periods). It also helps in the maintenance of pregnancy in women who are at higher risk of miscarriage. It should be taken with food. It may cause sleepiness or drowsiness. If this happens to you, do not drive or use machinery.
Ultigest -SR 200 Tablet is a progesterone (female hormone). It helps to establish and maintain pregnancy. It also prevents the increase in thickness of the endometrium (lining of the uterus) caused by estrogen.
What is Ultigest -SR 200 Tablet?
Ultigest -SR 200 Tablet is a micronized form of plant-derived progesterone. This process reduces the particle size of natural progesterone for improved dissolution and absorption, leading to better bioavailability within the body and potentially fewer side effects.
What is Ultigest -SR 200 Tablet used to treat?
Ultigest -SR 200 Tablet is prescribed for various conditions. It's used to manage secondary amenorrhea (absence of menstruation for three months in women who have experienced menstrual periods before). This medicine can also support pregnancy, prevent premature labor, and address bleeding disorders that may occur before menopause. It may be part of fertility treatments or used as hormone replacement therapy after menopause. Additionally, it is used to alleviate symptoms associated with premenstrual syndrome (PMS) and painful bleeding like in dysfunctional uterine bleeding.
Can you take Ultigest -SR 200 Tablet every day?
Yes, Ultigest -SR 200 Tablet can be taken daily. It is usually prescribed to be taken once daily in the evening or at bedtime. However, the duration of treatment may vary from 10-12 days per month to 25 days per month. Your doctor will determine the specific length of treatment based on your individual health status.
Does Ultigest -SR 200 Tablet cause weight gain?
Yes, taking Ultigest -SR 200 Tablet may contribute to weight gain. This potential effect might be attributed to water retention and is generally not considered serious. However, if you're concerned about any significant changes in your weight, consult your doctor immediately.
Is Ultigest -SR 200 Tablet safe?
Ultigest -SR 200 Tablet is generally safer compared to synthetic progesterone. Its smaller size allows for easier absorption and reduces potential side effects such as fluid retention, HDL cholesterol reduction, headaches, and mood disturbance.
How is progesterone beneficial for fertility and pregnancy?
Progesterone plays a vital role in both fertility and pregnancy. It's a crucial hormone secreted by the ovaries that prepares the uterus for a potential pregnancy and maintains it. Ultigest -SR 200 Tablet (a micronized form of plant-derived progesterone) is prescribed to support uterine preparation for pregnancy and prevent abortions in some cases. Additionally, it can help avoid premature labor.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Ultigest -SR 200 Tablet is to be taken with food.
Alcohol
It is not known whether it is safe to consume alcohol with Ultigest -SR 200 Tablet. Please consult your doctor.
Breastfeed
Ultigest -SR 200 Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Pregnancy
Ultigest -SR 200 Tablet is safe to use during pregnancy. Most studies have shown low or no risk to the developing baby.